510(k) Report

510(k) · Cleared

Cleared

MOTO PFJ System

K200122510(k) TraditionalCleared Apr 20, 202090-day reviewClass II21 CFR 888.3540

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medacta International S.A. · KRR Prosthesis, Knee, Patello/Femoral, Semi-Constrained, Cemented, Metal/Polymer

Cleared on Apr 20, 2020 as substantially equivalent to K070695 (Zimmer, Inc., 2007) and 1 other predicate after a 90-day review. Its family tree reaches back 4 generations to 1995. 2 later devices descend from it.

Decided
Apr 20, 2020
Review
90 days
Class
Class II
Product code
KRR
Recalls
None
Predicates
2

Its longest line of descent runs back 4 generations to K933785 (1995). 8 ancestors in all. 2 later devices descend from it, 1 citing it directly.

Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor2 generations back: 2 other ancestors3 generations back: 1 other ancestor 1 generation forward: 1 descendant2 generations forward: 1 descendant K070695 · Zimmer Patellofemoral Joint Prosthesis · Zimmer, Inc. · 2007 · recalledK060370 · Nexgen Knee Gender Solutions Female (GSF) Femoral Components · Zimmer, Inc. · 2006 · recalledK023211 · Nexgen Complete Knee Solution Cruciate Retaining (CR)-Flex Femoral Components · Zimmer, Inc. · 2002 · recalledK933785 · Next Generation Knee System · Zimmer, Inc. · 1995 · recalled0
  1. Root · 4 generations backK933785 Next Generation Knee SystemZimmer, Inc. · 1995 · Recalled
  2. 3 generations backK023211 Nexgen Complete Knee Solution Cruciate Retaining (CR)-Flex Femoral…Zimmer, Inc. · 2002 · Recalled
  3. 2 generations backK060370 Nexgen Knee Gender Solutions Female (GSF) Femoral ComponentsZimmer, Inc. · 2006 · Recalled
  4. 1 generation backK070695 Zimmer Patellofemoral Joint ProsthesisZimmer, Inc. · 2007 · Recalled
  5. This deviceK200122 MOTO PFJ SystemMedacta International S.A. · 2020
  6. Descendant · cites it directly · 1 of its ownK213071 MOTOTM Partial Knee & MOTO PFJ Systems ExtensionMedacta International S.A. · 2021
  7. Descendant · 2 generations on · 0 of its ownK251618 MOTO Partial Knee System ExtensionMedacta International S.A. · 2025

Most influential descendants

Showing 2 of 2 · See all
  • K213071MOTOTM Partial Knee & MOTO PFJ Systems ExtensionMedacta International S.A. · 2021 · cites it directly1descendant
  • K251618MOTO Partial Knee System ExtensionMedacta International S.A. · 2025 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K933785Next Generation Knee SystemZimmer, Inc.199583
−3K023211Nexgen Complete Knee Solution Cruciate Retaining (CR)-Flex Femoral ComponentsZimmer, Inc.20026
−2K060370Nexgen Knee Gender Solutions Female (GSF) Femoral ComponentsZimmer, Inc.200617
−1K070695Zimmer Patellofemoral Joint ProsthesisZimmer, Inc.20075
0 (this device)K200122MOTO PFJ SystemMedacta International S.A.2020—
+1K213071MOTOTM Partial Knee & MOTO PFJ Systems ExtensionMedacta International S.A.2021—
+2K251618MOTO Partial Knee System ExtensionMedacta International S.A.2025—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199910
200010
200510
200710

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202110
202510
FIG. 1 — Lineage of K200122, 1995–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KRR? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KRR device

  1. #1 K231253 Overture Orthopaedics Patellofemoral Systemscore 5.6 · 1 generation · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K070695Zimmer Patellofemoral Joint Prosthesis
Summary page 4
…60 Device Classification II III. Predicate Device Substantial equivalence is claimed to the following devices: ¾ Patellofemoral joint prosthesis, K070695, Zimmer ¾ NexGen Prolong All-poly patella, K072281, Zimmer In addition, the following Reference device is cited within th…
Zimmer, Inc.20075
*K072281Nexgen Prolong All-Poly Patella
Summary page 4
…Device Substantial equivalence is claimed to the following devices: ¾ Patellofemoral joint prosthesis, K070695, Zimmer ¾ NexGen Prolong All-poly patella, K072281, Zimmer In addition, the following Reference device is cited within the submission: ¾ GMK (K090988), Medacta Internation…
Zimmer, Inc.2007—
†K090988GMK Total Knee SystemMedacta International S.A.20091

Also cleared against K070695: 2 other devices →

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K213071MOTOTM Partial Knee & MOTO PFJ Systems ExtensionMedacta International S.A.20211

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 25 years and passes through 2 companies; a new generation was cleared every 7.7 years on median.
  • 6 of the 8 ancestors have a recall of any class.
  • Of its descendants, K213071 (Medacta International S.A., 2021) has gone furthest, with 1 descendant of its own.
  • 2 other devices also cite its predicate K070695.

How does its category compare?

All KRR devices

KRR Prosthesis, Knee, Patello/Femoral, Semi-Constrained, Cemented, Metal/Polymer: FDA decisions, review times, recalls and adverse event reports over 20 years. 2020, this device’s year, is highlighted.

FDA decisions per year · KRR

1in 2023

2007: 22008: 32012: 12013: 12015: 12016: 12018: 12020: 12021: 12022: 12023: 1
2007high 3 (2008) · low 0 (2009)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KRR

116in 2008

2008: 116 days median
2007high 116 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KRR

3in 2022

2013: 12016: 12017: 22022: 3
2007high 3 (2022) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KRR

36in 2025

2009: 122010: 62011: 32012: 92013: 92014: 262015: 182016: 142017: 152018: 142019: 162020: 62021: 82022: 92023: 122024: 252025: 36
2007high 36 (2025) · low 0 (2007)2025

MAUDE reports naming product code KRR, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
2008311600
20090—012
20100—06
20110—03
20121—09
20131—19
20140—026
20151—018
20161—114
20170—215
20181—014
20190—016
20201—06
20211—08
20221—39
20231—012
20240—025
20250—036
20260—0—

What is it indicated for?

The MOTO PFJ is designed for cemented use in partial knee arthroplasty, if there is evidence of enough sound bone to seat and support the components. Patellofemoral replacement is indicated in the following cases: Osteoarthritis, post-traumatic arthritis, polyarthritis, severe chondrocalcinosis of the patellofemoral joint. Previously failed surgical attempts (i.e. arthroscopy, lateral release, tibial tubercle elevation, cartilage transplantation).…

Read the full statement (111 words)

The MOTO PFJ is designed for cemented use in partial knee arthroplasty, if there is evidence of enough sound bone to seat and support the components. Patellofemoral replacement is indicated in the following cases:

Osteoarthritis, post-traumatic arthritis, polyarthritis, severe chondrocalcinosis of the patellofemoral joint.

Previously failed surgical attempts (i.e. arthroscopy, lateral release, tibial tubercle elevation, cartilage transplantation).

History of patellar dislocation or fracture, resulting in cartilage degeneration of the patellofemoral joint.

Degeneration induced by dysplasia.

If the surgeon evaluates an unequivocal indication for replacement of the patellofemoral joint, with or without a patella resurfacing, which outweighs the risks associated with the surgery, PFJ replacement may be considered, particularly for young patients.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K200122: MOTO PFJ System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K200122

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026